Wealth Enhancement Advisory Services LLC grew its holdings in Tempus AI, Inc. (NASDAQ:TEM – Free Report) by 6.1% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,681 shares of the company’s stock after acquiring an additional 560 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Tempus AI were worth $590,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. Cherry Tree Wealth Management LLC bought a new stake in shares of Tempus AI in the first quarter worth about $31,000. University of Texas Texas AM Investment Management Co. bought a new stake in shares of Tempus AI in the first quarter worth about $33,000. Bartlett & CO. Wealth Management LLC increased its holdings in shares of Tempus AI by 100.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company’s stock worth $39,000 after acquiring an additional 400 shares in the last quarter. Nemes Rush Group LLC bought a new stake in shares of Tempus AI in the first quarter worth about $39,000. Finally, Continuum Advisory LLC bought a new position in shares of Tempus AI during the first quarter worth about $39,000. 24.22% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on TEM shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Tempus AI in a report on Saturday, September 27th. BTIG Research raised their price objective on Tempus AI from $75.00 to $85.00 and gave the company a “buy” rating in a research report on Wednesday, August 20th. HC Wainwright raised their price objective on Tempus AI from $90.00 to $98.00 and gave the company a “buy” rating in a research report on Friday, September 12th. Piper Sandler reaffirmed a “neutral” rating on shares of Tempus AI in a research report on Friday, August 8th. Finally, Bank of America raised their price objective on Tempus AI from $68.00 to $70.00 and gave the company a “neutral” rating in a research report on Wednesday, June 25th. Seven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $71.83.
Tempus AI Trading Up 2.6%
Shares of TEM opened at $91.66 on Friday. The company has a debt-to-equity ratio of 2.58, a quick ratio of 1.43 and a current ratio of 1.54. Tempus AI, Inc. has a 52-week low of $31.36 and a 52-week high of $97.79. The firm has a market cap of $15.92 billion, a price-to-earnings ratio of -77.03 and a beta of 4.87. The business’s fifty day moving average is $74.98 and its 200-day moving average is $63.29.
Tempus AI (NASDAQ:TEM – Get Free Report) last released its quarterly earnings data on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The company had revenue of $314.64 million for the quarter, compared to the consensus estimate of $296.84 million. During the same quarter last year, the business posted ($6.86) EPS. Tempus AI’s revenue for the quarter was up 89.5% on a year-over-year basis. Tempus AI has set its FY 2025 guidance at EPS. Equities analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.
Insider Activity
In other Tempus AI news, CEO Eric P. Lefkofsky sold 332,500 shares of Tempus AI stock in a transaction dated Thursday, September 25th. The stock was sold at an average price of $76.56, for a total transaction of $25,456,200.00. Following the transaction, the chief executive officer directly owned 9,141,032 shares of the company’s stock, valued at approximately $699,837,409.92. The trade was a 3.51% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Ryan Fukushima sold 17,460 shares of Tempus AI stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $1,303,389.00. Following the transaction, the chief operating officer directly owned 839,180 shares in the company, valued at $62,644,787. The trade was a 2.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 933,662 shares of company stock worth $67,909,393. 26.27% of the stock is owned by corporate insiders.
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Featured Articles
- Five stocks we like better than Tempus AI
- What is Forex and How Does it Work?
- Why the Precious Metal Nobody Talks About Could Be Your Best Bet
- Compound Interest and Why It Matters When Investing
- Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback
- Investing in Travel Stocks Benefits
- 3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.